Auxilius
R&D Accrual & Forecast Automation for Biopharma
New York, United States · Founded 2020 · $10.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- auxilius.co
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AJun 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
R&D financial automation software for biopharma companies managing clinical trial costs.
Summary
Auxilius is a Biotech company based in New York, United States, founded in 2020. It has raised $10.0M in total across 2 rounds, most recently a $10.0M Series A round in Jun 2024. Investors include SignalFire, Renegade Partners and Bain Capital Ventures.
Tech & App Stack
22 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Fireblocks provides digital asset and stablecoin infrastructure, enabling organizations to secure...
Quest Software provides data management, cybersecurity, and platform-modernization technology tha...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/auxilius"><img src="https://indexed.vc/api/badge/company/auxilius" alt="Auxilius on Indexed.vc" width="260" height="76" /></a>